A new international study has explored how different bone-strengthening medications affect people after they suffer a hip ...

May 13, 2011— -- Many doctors are changing the prescribing length of a class of osteoporosis medication known as bisphosphonates after mounting evidence has linked long-term use of the medication ...

Background and Objective: Despite their widespread use in metastatic bone disease, some bisphosphonate drugs are associated with adverse events (AEs), particularly renal toxicity, adding to treatment ...

In a national study of older Danes who had previously had a fracture and were taking bisphosphonates, the risk of having a serious though rare atypical femoral fracture (AFF) was greater after 3 to 5 ...

Dear Dr. Roach: I am an active, 5-foot-2-inch, 125-pound, 72-year-old Caucasian woman without a history of known osteoporotic risk factors, other than demographic ones. I exercise daily, eat calcium ...

Please provide your email address to receive an email when new articles are posted on . Compared with oral bisphosphonate use, denosumab use was associated with a 45% lower risk for fractures among ...

Data suggest a protective association of bisphosphonates against having a kidney stone diagnosis or procedure. Patients receiving bisphosphonates for osteoporosis treatment are less likely to have ...